MedPath

Study the effects of atibala churna in raktapradar (menorraghia)

Phase 1
Conditions
Health Condition 1: R651- Systemic inflammatory response syndrome (SIRS) of non-infectious origin
Registration Number
CTRI/2023/04/051404
Lead Sponsor
Dr Ravina kamdar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Female patients from age group of 12-50 years

Patients with Lakshana of Raktapradar like prolong, excessive menstrual bleeding or intermenstrual bleeding

Exclusion Criteria

Patient having other associated complications such as Fibroid, Polyp, Malignancy, Hypertension,Tuberculosis, Diabetes mellitus,inter uterine devices was excluded from study point of view.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of Atibala Churna in Raktapradar (Menorraghia)Timepoint: In Raktapradar Patients with 1 Month study with Follow Up on 5 th day 10 th day and on Next Month Menstrual Cycle .
Secondary Outcome Measures
NameTimeMethod
To observe the adverse effects of Atibala churna , if anyTimepoint: 4 FOLLOW UPS <br/ ><br> 1st - day 2 <br/ ><br> 2nd- day 5 <br/ ><br> 3rd- day 10 <br/ ><br> 4TH â?? DURING NEXT
© Copyright 2025. All Rights Reserved by MedPath